{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:41:55Z","timestamp":1790804515967,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>MicroRNAs (miRNAs) play important roles in the fibrosis of systemic sclerosis (SSc). However, the underlying miRNA-mRNA regulatory network is not fully understood. A systemic investigation of the role of miRNAs would be very valuable for increasing our knowledge of the pathogenesis of SSc. Here, we combined miRNA and mRNA expression profiles and bioinformatics analyses and then performed validation experiments. we identified 21 miRNAs and 2698 mRNAs that were differentially expressed in SSc. Among these, 17 miRNAs and their 33 target mRNAs (55 miRNA-mRNA pairs) were involved in Toll-like receptor, transforming growth factor \u03b2 and Wnt signalling pathways. Validation experiments revealed that miR-146b, miR-130b, miR-21, miR-31 and miR-34a levels were higher whereas miR-145 levels were lower in SSc skin tissues and fibroblasts, normal fibroblasts and endothelial cells that were stimulated with SSc serum. ACVR2B, FZD2, FZD5 and SOX2 levels were increased in SSc skin fibroblasts, normal fibroblasts and endothelial cells that were stimulated with SSc serum. We did not identify any negative correlations among these miRNA-mRNA pairs. miR-21 was specifically expressed at higher levels in SSc serum. Six miRNAs and 4 mRNAs appear to play important roles in the pathogenesis of SSc are worth investigating in future functional studies.<\/jats:p>","DOI":"10.1038\/srep42899","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T05:34:14Z","timestamp":1487309654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients"],"prefix":"10.1038","volume":"7","author":[{"given":"Bin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Xia","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Dan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"BFsrep42899_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","volume":"10","author":"YY Ho","year":"2014","unstructured":"Ho, Y. Y., Lagares, D., Tager, A. M. & Kapoor, M. Fibrosis\u2013a lethal component of systemic sclerosis. Nat Rev Rheumatol 10, 390\u2013402, doi: 10.1038\/nrrheum.2014.53 (2014).","journal-title":"Nat Rev Rheumatol"},{"key":"BFsrep42899_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrrheum.2012.99","volume":"8","author":"R Lafyatis","year":"2012","unstructured":"Lafyatis, R. Connective tissue disease: SSc-fibrosis takes flight with Wingless inhibition. Nat Rev Rheumatol 8, 441\u2013442, doi: 10.1038\/nrrheum.2012.99 (2012).","journal-title":"Nat Rev Rheumatol"},{"key":"BFsrep42899_CR3","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy, E. C. et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15, 202\u2013205 (1988).","journal-title":"J Rheumatol"},{"key":"BFsrep42899_CR4","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore, Y. et al. Systemic sclerosis. Nature reviews. Disease primers 1, 15002, doi: 10.1038\/nrdp.2015.2 (2015).","journal-title":"Nature reviews. Disease primers"},{"key":"BFsrep42899_CR5","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1002\/art.21355","volume":"52","author":"X Zhou","year":"2005","unstructured":"Zhou, X., Tan, F. K., Xiong, M., Arnett, F. C. & Feghali-Bostwick, C. A. Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles. Arthritis Rheum 52, 3305\u20133314, doi: 10.1002\/art.21355 (2005).","journal-title":"Arthritis Rheum"},{"key":"BFsrep42899_CR6","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli, A., Avvedimento, E. V. & Krieg, T. Scleroderma. The New England journal of medicine 360, 1989\u20132003, doi: 10.1056\/NEJMra0806188 (2009).","journal-title":"The New England journal of medicine"},{"key":"BFsrep42899_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","volume":"10","author":"JC Broen","year":"2014","unstructured":"Broen, J. C., Radstake, T. R. & Rossato, M. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat Rev Rheumatol 10, 671\u2013681, doi: 10.1038\/nrrheum.2014.128 (2014).","journal-title":"Nat Rev Rheumatol"},{"key":"BFsrep42899_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/1346-8138.13221","volume":"43","author":"T Makino","year":"2016","unstructured":"Makino, T. & Jinnin, M. Genetic and epigenetic abnormalities in systemic sclerosis. J Dermatol 43, 10\u201318, doi: 10.1111\/1346-8138.13221 (2016).","journal-title":"J Dermatol"},{"key":"BFsrep42899_CR9","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/rheumatology\/keu155","volume":"54","author":"N Altorok","year":"2015","unstructured":"Altorok, N., Almeshal, N., Wang, Y. & Kahaleh, B. Epigenetics, the holy grail in the pathogenesis of systemic sclerosis. Rheumatology (Oxford) 54, 1759\u20131770, doi: 10.1093\/rheumatology\/keu155 (2015).","journal-title":"Rheumatology (Oxford)"},{"key":"BFsrep42899_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"J Krol","year":"2010","unstructured":"Krol, J., Loedige, I. & Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nature reviews. Genetics 11, 597\u2013610, doi: 10.1038\/nrg2843 (2010).","journal-title":"Nature reviews. Genetics"},{"key":"BFsrep42899_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/08916934.2014.929667","volume":"47","author":"L Zeng","year":"2014","unstructured":"Zeng, L., Cui, J., Wu, H. & Lu, Q. The emerging role of circulating microRNAs as biomarkers in autoimmune diseases. Autoimmunity 47, 419\u2013429, doi: 10.3109\/08916934.2014.929667 (2014).","journal-title":"Autoimmunity"},{"key":"BFsrep42899_CR12","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s10875-013-9896-z","volume":"33","author":"H Zhu","year":"2013","unstructured":"Zhu, H. et al. MicroRNA-21 in scleroderma fibrosis and its function in TGF-beta-regulated fibrosis-related genes expression. J Clin Immunol 33, 1100\u20131109, doi: 10.1007\/s10875-013-9896-z (2013).","journal-title":"J Clin Immunol"},{"key":"BFsrep42899_CR13","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/art.27443","volume":"62","author":"B Maurer","year":"2010","unstructured":"Maurer, B. et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62, 1733\u20131743, doi: 10.1002\/art.27443 (2010).","journal-title":"Arthritis Rheum"},{"key":"BFsrep42899_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3109\/14397595.2014.1001311","volume":"25","author":"H Luo","year":"2015","unstructured":"Luo, H., Zhu, H., Zhou, B., Xiao, X. & Zuo, X. MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor gamma. Modern rheumatology\/the Japan Rheumatism Association 25, 595\u2013602, doi: 10.3109\/14397595.2014.1001311 (2015).","journal-title":"Modern rheumatology\/the Japan Rheumatism Association"},{"key":"BFsrep42899_CR15","doi-asserted-by":"publisher","first-page":"19231","DOI":"10.1073\/pnas.1013162107","volume":"107","author":"NK Vo","year":"2010","unstructured":"Vo, N. K., Dalton, R. P., Liu, N., Olson, E. N. & Goodman, R. H. Affinity purification of microRNA-133a with the cardiac transcription factor, Hand2. Proceedings of the National Academy of Sciences of the United States of America 107, 19231\u201319236, doi: 10.1073\/pnas.1013162107 (2010).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep42899_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrg3162","volume":"13","author":"AE Pasquinelli","year":"2012","unstructured":"Pasquinelli, A. E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nature reviews. Genetics 13, 271\u2013282, doi: 10.1038\/nrg3162 (2012).","journal-title":"Nature reviews. Genetics"},{"key":"BFsrep42899_CR17","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1038\/emm.2013.71","volume":"45","author":"H Zhu","year":"2013","unstructured":"Zhu, H., Luo, H. & Zuo, X. MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma. Experimental & molecular medicine 45, e41, doi: 10.1038\/emm.2013.71 (2013).","journal-title":"Experimental & molecular medicine"},{"key":"BFsrep42899_CR18","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1093\/nar\/gkt525","volume":"41","author":"M van Iterson","year":"2013","unstructured":"van Iterson, M. et al. Integrated analysis of microRNA and mRNA expression: adding biological significance to microRNA target predictions. Nucleic acids research 41, e146, doi: 10.1093\/nar\/gkt525 (2013).","journal-title":"Nucleic acids research"},{"key":"BFsrep42899_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s10875-011-9647-y","volume":"32","author":"H Zhu","year":"2012","unstructured":"Zhu, H. et al. MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma. J Clin Immunol 32, 514\u2013522, doi: 10.1007\/s10875-011-9647-y (2012).","journal-title":"J Clin Immunol"},{"key":"BFsrep42899_CR20","doi-asserted-by":"publisher","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","volume":"3","author":"A Milano","year":"2008","unstructured":"Milano, A. et al. Molecular subsets in the gene expression signatures of scleroderma skin. PloS one 3, e2696, doi: 10.1371\/journal.pone.0002696 (2008).","journal-title":"PloS one"},{"key":"BFsrep42899_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. The Journal of cell biology 200, 373\u2013383, doi: 10.1083\/jcb.201211138 (2013).","journal-title":"The Journal of cell biology"},{"key":"BFsrep42899_CR22","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1371\/journal.pbio.0050229","volume":"5","author":"E Levine","year":"2007","unstructured":"Levine, E., Zhang, Z., Kuhlman, T. & Hwa, T. Quantitative characteristics of gene regulation by small RNA. PLoS biology 5, e229, doi: 10.1371\/journal.pbio.0050229 (2007).","journal-title":"PLoS biology"},{"key":"BFsrep42899_CR23","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/ng.905","volume":"43","author":"S Mukherji","year":"2011","unstructured":"Mukherji, S. et al. MicroRNAs can generate thresholds in target gene expression. Nature genetics 43, 854\u2013859, doi: 10.1038\/ng.905 (2011).","journal-title":"Nature genetics"},{"key":"BFsrep42899_CR24","doi-asserted-by":"publisher","first-page":"e1001101","DOI":"10.1371\/journal.pcbi.1001101","volume":"7","author":"M Osella","year":"2011","unstructured":"Osella, M., Bosia, C., Cora, D. & Caselle, M. The role of incoherent microRNA-mediated feedforward loops in noise buffering. PLoS computational biology 7, e1001101, doi: 10.1371\/journal.pcbi.1001101 (2011).","journal-title":"PLoS computational biology"},{"key":"BFsrep42899_CR25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nature09144","volume":"465","author":"L Poliseno","year":"2010","unstructured":"Poliseno, L. et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033\u20131038, doi: 10.1038\/nature09144 (2010).","journal-title":"Nature"},{"key":"BFsrep42899_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ajpath.2012.09.023","volume":"182","author":"N Honda","year":"2013","unstructured":"Honda, N. et al. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin beta3. The American journal of pathology 182, 206\u2013216, doi: 10.1016\/j.ajpath.2012.09.023 (2013).","journal-title":"The American journal of pathology"},{"key":"BFsrep42899_CR27","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/jid.2012.22","volume":"132","author":"K Kashiyama","year":"2012","unstructured":"Kashiyama, K. et al. miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts. The Journal of investigative dermatology 132, 1597\u20131604, doi: 10.1038\/jid.2012.22 (2012).","journal-title":"The Journal of investigative dermatology"},{"key":"BFsrep42899_CR28","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.4049\/jimmunol.1200822","volume":"190","author":"K Makino","year":"2013","unstructured":"Makino, K. et al. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma. Journal of immunology 190, 3905\u20133915, doi: 10.4049\/jimmunol.1200822 (2013).","journal-title":"Journal of immunology"},{"key":"BFsrep42899_CR29","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/rheumatology\/kes120","volume":"51","author":"T Sing","year":"2012","unstructured":"Sing, T. et al. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma. Rheumatology (Oxford) 51, 1550\u20131556, doi: 10.1093\/rheumatology\/kes120 (2012).","journal-title":"Rheumatology (Oxford)"},{"key":"BFsrep42899_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/ITT.S82037","volume":"5","author":"P Fuschiotti","year":"2016","unstructured":"Fuschiotti, P. Current perspectives on the immunopathogenesis of systemic sclerosis. ImmunoTargets and therapy 5, 21\u201335, doi: 10.2147\/ITT.S82037 (2016).","journal-title":"ImmunoTargets and therapy"},{"key":"BFsrep42899_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/labinvest.2015.154","volume":"96","author":"C Bergmann","year":"2016","unstructured":"Bergmann, C. & Distler, J. H. Canonical Wnt signaling in systemic sclerosis. Laboratory investigation; a journal of technical methods and pathology 96, 151\u2013155, doi: 10.1038\/labinvest.2015.154 (2016).","journal-title":"Laboratory investigation; a journal of technical methods and pathology"},{"key":"BFsrep42899_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.autrev.2010.09.015","volume":"10","author":"J Wei","year":"2011","unstructured":"Wei, J., Bhattacharyya, S., Tourtellotte, W. G. & Varga, J. Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy. Autoimmunity reviews 10, 267\u2013275, doi: 10.1016\/j.autrev.2010.09.015 (2011).","journal-title":"Autoimmunity reviews"},{"key":"BFsrep42899_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/ncomms1734","volume":"3","author":"A Akhmetshina","year":"2012","unstructured":"Akhmetshina, A. et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nature communications 3, 735, doi: 10.1038\/ncomms1734 (2012).","journal-title":"Nature communications"},{"key":"BFsrep42899_CR34","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.yexcr.2012.12.023","volume":"319","author":"M Reis","year":"2013","unstructured":"Reis, M. & Liebner, S. Wnt signaling in the vasculature. Experimental cell research 319, 1317\u20131323, doi: 10.1016\/j.yexcr.2012.12.023 (2013).","journal-title":"Experimental cell research"},{"key":"BFsrep42899_CR35","doi-asserted-by":"crossref","unstructured":"Distler, J. H. et al. Frontiers of antifibrotic therapy in systemic sclerosis. Arthritis Rheumatol, doi: 10.1002\/art.39865 (2016).","DOI":"10.1002\/art.39865"},{"key":"BFsrep42899_CR36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/exd.12255","volume":"22","author":"C Dees","year":"2013","unstructured":"Dees, C. & Distler, J. H. Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies? Experimental dermatology 22, 710\u2013713, doi: 10.1111\/exd.12255 (2013).","journal-title":"Experimental dermatology"},{"key":"BFsrep42899_CR37","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrrheum.2014.19","volume":"10","author":"EI Buzas","year":"2014","unstructured":"Buzas, E. I., Gyorgy, B., Nagy, G., Falus, A. & Gay, S. Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol 10, 356\u2013364, doi: 10.1038\/nrrheum.2014.19 (2014).","journal-title":"Nat Rev Rheumatol"},{"key":"BFsrep42899_CR38","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature cell biology 9, 654\u2013659, doi: 10.1038\/ncb1596 (2007).","journal-title":"Nature cell biology"},{"key":"BFsrep42899_CR39","doi-asserted-by":"publisher","first-page":"e41561","DOI":"10.1371\/journal.pone.0041561","volume":"7","author":"K Wang","year":"2012","unstructured":"Wang, K. et al. Comparing the MicroRNA spectrum between serum and plasma. PloS one 7, e41561, doi: 10.1371\/journal.pone.0041561 (2012).","journal-title":"PloS one"},{"key":"BFsrep42899_CR40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","volume":"50","author":"EM Kroh","year":"2010","unstructured":"Kroh, E. M., Parkin, R. K., Mitchell, P. S. & Tewari, M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50, 298\u2013301, doi: 10.1016\/j.ymeth.2010.01.032 (2010).","journal-title":"Methods"},{"key":"BFsrep42899_CR41","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 105, 10513\u201310518, doi: 10.1073\/pnas.0804549105 (2008).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep42899_CR42","doi-asserted-by":"publisher","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","volume":"3","author":"S Gilad","year":"2008","unstructured":"Gilad, S. et al. Serum microRNAs are promising novel biomarkers. PloS one 3, e3148, doi: 10.1371\/journal.pone.0003148 (2008).","journal-title":"PloS one"},{"key":"BFsrep42899_CR43","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan, E. M. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25, 1271\u20131277 (1982).","journal-title":"Arthritis Rheum"},{"key":"BFsrep42899_CR44","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (second of two parts). The New England journal of medicine 292, 403\u2013407, doi: 10.1056\/NEJM197502202920807 (1975).","journal-title":"The New England journal of medicine"},{"key":"BFsrep42899_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 4, 44\u201357, doi: 10.1038\/nprot.2008.211 (2009).","journal-title":"Nature protocols"},{"key":"BFsrep42899_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research 37, 1\u201313, doi: 10.1093\/nar\/gkn923 (2009).","journal-title":"Nucleic acids research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep42899","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42899.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42899.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T14:50:54Z","timestamp":1671807054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep42899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,9]]}},"alternative-id":["BFsrep42899"],"URL":"https:\/\/doi.org\/10.1038\/srep42899","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]},"assertion":[{"value":"31 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42899"}}